Hemo AI
AI-powered IV Blood Monitoring Medical Device
Startup Pre-Funding Health Tech & Life Sciences Est. 2023
Total Raised
Undisclosed
Pre-Funding
Last Round
Undisclosed
Team
4
1-10 employees
Confidence
78/100
Patents
1
About
Hemo-ai is developing a solution with real-time alerts for bleeding and sepsis, enhancing patient care and revolutionizing traditional monitoring methods. The company's system provides an automated, wearable, IV blood monitoring system that integrates data aggregation and AI analysis, making it ideal for use in hospitals, ICUs, ambulances, and field hospitals.
Classification
Sector
Health Tech & Life Sciences
Core Technology
Artificial IntelligencePlatforms & Interfaces
Target Customer
Government & CityDefense, Safety & SecuritySafetyHealthcare & Life Sciences
Business Model
B2B
Tags
healthcaredual-usedefenseartificial-intelligencediagnostics
Details
Product Stage
R&D
Employees
1-10
Exact Count
4
District
Center District
Founded
2023
Registrar
516878212
Locations
Ha-Shoshana St 18, Binyamina-Giv'at Ada, Israel
Links
Admin
Last Update
Jul 30, 2025
Verified by
Matan Eblagon
Claimed
Yes
Missing
sector, video or image, funding rounds, news, markets, external profiles, not claimed
Team (4)
Liron Ben-Bashat Bergman
Co-founder & CEO
Founder
David Salton
Co-Founder & CBO
Founder
Ron Beloosesky
Co-Founder & Clinical Officer
Founder
Gilad Cohen
Co-Founder and CTO
Founder
Internal
Created by
Matan Eblagon (matane@sncentral.org)
Created
2025-05-26T00:00:00.000Z